Buy Aemetis As It Hits Multiple Catalysts In 2026

Aemetis is positioned for significant growth, driven by layered tax credits and operational catalysts across biofuels, RNG, and carbon capture. I rate AMTX a strong buy for risk-tolerant growth investors, citing imminent profitability, major tax credit monetization, and mounting need for biofuels. Projecting $400M in 45Z tax credit revenue through 2029, with further upside if credits are extended, underpins a compelling margin expansion story.